What is an IgVH mutation analysis?
Jessica Hardy What is an IgVH mutation analysis?
Test Details The IgVH gene mutation status is one of the discriminators of clinical outcome in patients with CLL. The mutational status of the immunoglobulin genes expressed by CLL cells can be used to segregate patients into two subsets that have significantly different tendencies for disease progression.
What does unmutated mean in CLL?
In CLL cells that proliferated at a high rate, a high-utility repair mechanism is engaged; as a result, the IgHV mutation level is low (or “unmutated”). Conversely, in CLL cells that proliferated at a low rate, a low-utility repair mechanism is engaged; as a result, the IgHV mutation level is high (or “mutated”).
What is FISH test for CLL?
A FISH test looks for a small number of specific changes in genes or chromosomes in the chronic lymphocytic leukaemia (CLL) cells. It gives information about the gene changes in chromosomes, such as whether a part is missing or ‘deleted’. Information from these tests helps doctors know how well certain drugs may work.
What is IGHV gene?
IGHV is the immunoglobulin heavy chain variable region genes; in B-cell neoplasms like chronic lymphocytic leukemia, mutations of IGHV are associated with better responses to some treatments and with prolonged survival.
What is the life expectancy of someone with CLL?
The prognosis of patients with CLL varies widely at diagnosis. Some patients die rapidly, within 2-3 years of diagnosis, because of complications from CLL. Most patients live 5-10 years, with an initial course that is relatively benign but followed by a terminal, progressive, and resistant phase lasting 1-2 years.
Why is the IgVH region gene testing important?
IGHV testing is a useful prognostic tool for patients with CLL. IGHV status may also have prognostic implications in other lymphomas, such as follicular and mantle cell lymphoma.
What is 13q deletion in CLL?
Deletion of 13q14 [del(13q)] is the most common cytogenetic change (50%) in chronic lymphoblastic leukemia (CLL), and it is a good prognostic factor if it is detected as a sole aberration by FISH.
What is 17p deletion in CLL?
In chronic lymphocytic leukemia (CLL), deletion (del) of the short arm of chromosome 17 (17p13) is found in 5 to 8% of patients requiring first-line treatment and is associated with rapid disease progression as well as a poor response to treatment with a median overall survival (OS) of 2 to 3 years from the time of …
Can IGHV mutation status change?
Mutations of the genes codifying for the immunoglobulin heavy chain variable region (IGHV) of the BCR represent one of the most robust prognostic biomarkers, and, indeed, was one of the first to be identified. IGHV mutations never change over time, and thus represent the fingerprint of the disease.
